Over the years cannabis has been known by numerous terms – marijuana, grass, pot, dope, mary jane, weed – and this is just a short sample. Interestingly, even as the sector prepares to take its place as a legitimate and sophisticated industry, the terminology used by mainstream media outlets
, commentators and advocates continues to fluctuate between words – even though all but the term cannabis carry negative connotations. Although cannabis and marijuana have been used interchangeably for many years – for some, the term “marijuana” comes with both a negative racial legacy and
associations of a well documented propaganda campaign to position cannabis as a dangerous and addictive intoxicant (the “reefer madness” years). Language and words have a power that transcends their formal meaning – they instantly set the tone and frame for perceptions and emotive connection. And for an industry still in the throes of establishing itself, this is essential. A recent poll by Angus Reid found that more than half of all respondents believe that the deadline for legalization should be pushed back to ensure that governments are better prepared. Consistent terminology is a seemingly simple but important step in helping mitigate negative feelings and stigmas still associated with the product and industry. Using the term cannabis consistently and widely, will help normalize the medical and scientific nature of the plant and by doing so, elevate the public’s understanding, education and acceptance. For Business of Cannabis, we will use only use the term cannabis and we encourage others to do the same.
A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.
Home / Why It’s “Cannabis” for Business of Cannabis
Why It’s “Cannabis” for Business of Cannabis
Over the years cannabis has been known by numerous terms – marijuana, grass, pot, dope, mary jane, weed – and this is just a short sample. Interestingly, even as the sector prepares to take its place as a legitimate and sophisticated industry, the terminology used by mainstream media outlets
, commentators and advocates continues to fluctuate between words – even though all but the term cannabis carry negative connotations. Although cannabis and marijuana have been used interchangeably for many years – for some, the term “marijuana” comes with both a negative racial legacy and
associations of a well documented propaganda campaign to position cannabis as a dangerous and addictive intoxicant (the “reefer madness” years). Language and words have a power that transcends their formal meaning – they instantly set the tone and frame for perceptions and emotive connection. And for an industry still in the throes of establishing itself, this is essential. A recent poll by Angus Reid found that more than half of all respondents believe that the deadline for legalization should be pushed back to ensure that governments are better prepared. Consistent terminology is a seemingly simple but important step in helping mitigate negative feelings and stigmas still associated with the product and industry. Using the term cannabis consistently and widely, will help normalize the medical and scientific nature of the plant and by doing so, elevate the public’s understanding, education and acceptance. For Business of Cannabis, we will use only use the term cannabis and we encourage others to do the same.
BofC
Other featured articles
Cannabis at an Inflexion Point: A Structural Repricing Ahead
By
Europe’s Medical Cannabis Market Has Grown Up, Now Its Supply Chain Needs To
By
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
By
From Green Success to BH Labs: Why the Next Cannabis Leaders Will Look More Like Technology Companies
By
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
By
Other featured Opinion articles
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
By
From Green Success to BH Labs: Why the Next Cannabis Leaders Will Look More Like Technology Companies
By
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
By
Is the ‘Commercial Scale’ of Medical Cannabis in the UK Inappropriate?
By
Is a Cannabis M&A Tidal Wave on the Way?
By
Share Article
The Briefing / Newsletter
Insights
you don't want
to miss.
A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.
Related news
Cannabis at an Inflexion Point: A Structural Repricing Ahead
By
Europe’s Medical Cannabis Market Has Grown Up, Now Its Supply Chain Needs To
By
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
By
From Green Success to BH Labs: Why the Next Cannabis Leaders Will Look More Like Technology Companies
By
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
By
Is the ‘Commercial Scale’ of Medical Cannabis in the UK Inappropriate?
By
Is a Cannabis M&A Tidal Wave on the Way?
By
Rescheduling Will Reprice Medical IP, Not Retail Footprints
By
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By